Chronic treatment with suprapharmacologic doses of peroxisome proliferator-activated receptor (PPAR) agonists has a known potential for causing left ventricular hypertrophy (LVH). The mechanism by which LVH develops is not well understood nor are biomarkers of it well characterized. Natriuretic peptides are important regulators of cardiac growth, blood volume, and arterial pressure and may be u...

B-type natriuretic peptide (BNP) and NT-proBNP are widely used plasma biomarkers for the diagnosis of acute decompensated heart failure and prognosis for future cardiac disease. The clinical performance of these tests for management of chronic heart failure is somewhat limited by the markers' high biological variation. Biomarkers such as galectin-3 and soluble ST2 that reflect ongoing remodelin...

Sensitive measurement of biomarkers is of great importance in biomedical research, disease monitoring, and clinical diagnosis. In particular, much attention has been recently directed to rapid and sensitive diagnostics in the point-of-care (POC) settings. For instance, cardiac biomarkers and diabetes biomarkers have been detected with POC devices that allow onthe-spot diagnosis, thereby facilit...

Little attention has been paid to the aspects of cardiac injury-related foot and mouth disease (FMD) in young animals. So, this research was conducted to evaluate the serum biomarkers and electrocardiographic (ECG) evidence of myocardial injury in the infected lambs with FMD. During an outbreak, 33 lambs with FMD and 11 healthy lambs were randomly enrolled. After blood sampling, ECGs were taken...

BACKGROUND The diagnosis of peri-procedural myocardial infarction is complex, especially after the emergence of high-sensitivity markers of myocardial necrosis. METHODS In this study, patients with normal baseline cardiac biomarkers and formal indication for elective on-pump coronary bypass surgery were evaluated. Electrocardiograms, cardiac biomarkers, and cardiac magnetic resonance imaging ...

Acute myocardial infarction (AMI) is a common cause of death for which effective treatments are available provided that diagnosis is rapid. The current diagnostic gold standards are circulating cardiac troponins I and T. However, their slow release delays diagnosis, and their persistence limits their utility in the identification of reinfarction. The aim was to identify candidate biomarkers of ...

OBJECTIVES This study sought to determine whether the combined trajectories of cardiac biomarkers identify those older adults with initial low levels who have an increased risk for structural heart disease, incident heart failure (HF), and cardiovascular (CV) death. BACKGROUND Initial low levels of high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-brain natriuretic peptide (NT-...

It has been known for 50 years that transaminase activity increases in patients with acute myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac injury began to take a major role in the diagnosis and management of patients with acute cardiovascular disease. In 2000 the European Society of Cardiology and the American College of Cardiology recognized the pivot...

MAJOR perioperative cardiac events in patients undergoing noncardiac surgery continue to be a significant source of perioperative morbidity with ranges from 1.4% in relatively unselected patients to 6% in patients older than 70 yr with cardiac disease. Moreover, perioperative myocardial infarction (PMI) is one of the most important predictors of shortand long-term morbidity and mortality associ...